Dear Reader,

As we reach the final issue of Drugs—Real World Outcomes for 2017, we wish to reflect on another successful year’s achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content.

2017 was a successful year for Drugs—Real World Outcomes. Over 25 articles have been published; the most popular of these, in terms of downloads from SpringerLink as at September 2017, have been:

Characterisation of Drug-Related Problems and Associated Factors at a Clinical Pharmacist Service-Naïve Hospital in Northern Sweden. Peterson, C. & Gustafsson, M. Drugs—Real World Outcomes (2017) 4: 97.

Examining the Quality of Medicines at Kenyan Healthcare Facilities: A Validation of an Alternative Post-Market Surveillance Model That Uses Standardized Patients. Wafula, F., Dolinger, A., Daniels, B. et al. Drugs—Real World Outcomes (2017) 4: 53.

HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes. Robert, N.J., Goertz, HP., Chopra, P. et al. Drugs - Real World Outcomes (2017) 4: 1.

Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case–Control Study in Australia. Leach, M.J., Pratt, N.L. & Roughead, E.E. Drugs—Real World Outcomes (2017) 4: 87.

Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study. Schäfer, U., Kienle-Gogolok, A., Hadler, M. et al. Drugs—Real World Outcomes (2017) 4: 109.

Characterization of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Admitted to Kenyatta National Hospital: A Retrospective Cross-Sectional Study. Irungu, K., Nyamu, D. & Opanga, S. Drugs—Real World Outcomes (2017) 4: 79.

Pharmacist’s Comprehensive Geriatric Assessment: Introduction and Evaluation at Elderly Patient Admission. Rhalimi, F., Rhalimi, M. & Rauss, A. Drugs—Real World Outcomes (2017) 4: 43.

Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Acute Myocardial Infarction in the General German Population: A Nested Case–Control Study. Thöne, K., Kollhorst, B. & Schink, T. Drugs—Real World Outcomes (2017) 4: 127.

Spontaneously Reported Adverse Reactions for Herbal Medicinal Products and Natural Remedies in Sweden 2007–15: Report from the Medical Products Agency. Svedlund, E., Larsson, M. & Hägerkvist, R. Drugs—Real World Outcomes (2017) 4: 119.

Tolerability of an Immunologically Enhanced Subcutaneous Immunotherapy Preparation in Patients Treated with Concomitant Allergy Immunotherapy: A Non-Interventional Observational Study. Reiber, R., Wolf, H., Schnitker, J. et al. Drugs—Real World Outcomes (2017) 4: 65.

Other journals in the Adis Premier Journals Portfolio (http://www.springer.com/gp/adis) continue to prosper, and this year has seen the successful launch of PharmacoEconomics—Open, the newest journal in the portfolio. The journal has published a full volume of 30 articles in its first year, plus many more online first. Following in the steps of Adis’ flagship subscription journal in the field, PharmacoEconomics, the new open-access journal focuses on cost and health outcomes associated with drugs, devices and other healthcare interventions.

We thank the authors who have contributed articles to Drugs—Real World Outcomes over the course of 2017. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for Drugs—Real World Outcomes in the last 12 months:

Sura Alwan, Canada

Mulugeta Tarekegn Angamo, Australia

Alejandro Arana, Spain

Joanne Barnes, New Zealand

Claudio Borghi, Italy

Rhiannon Braund, New Zealand

Shawn Bugden, Canada

Xiaoyan Cai, China

Ryan M. Carnahan, USA

Jongwha Chang, USA

Hsin-Hua Chen, Taiwan, Republic of China

Lita Chew, Singapore

Wen-Hung Chung, Taiwan, Republic of China

Al Cozzi-Lepri, UK

Alexander N. O. Dodoo, Ghana

Mahyar Etminan, Canada

Mercé Falip, Spain

José Carlos García Robaina, Spain

Danijela Gnjidic, Australia

Bertrand Guignard, Switzerland

Maria Gustafsson, Sweden

Richard A. Hansen, USA

Amany Hassan, USA

Lina Hellström, Sweden

Maria Teresa F. Herdeiro, Portugal

Daniel Horton, USA

Consuelo Huerta, Spain

Virva Hyttinen, Finland

Cristoforo Incorvaia, Italy

Kathrin Jobski, Germany

Lauren E. Kelly, Canada

Ronald Kiguba, Uganda

Karel Kostev, Germany

Shih-Wei Lai, Taiwan, Republic of China

Michele P. Lambert, USA

Marie-Laure Laroche, France

Myeong Soo Lee, Republic of Korea

Shing-Hwa Liu, Taiwan, Republic of China

Ersilia Lucenteforte, Italy

Yoann Madec, France

T. Joseph Mattingly II, USA

Ann W. McMahon, USA

Peter Mol, the Netherlands

Michael Mosier, USA

Yasuyuki Okumura, Japan

Sten Olsson, Sweden

Mei-Sing Ong, USA

Antoine Pariente, France

Carole Parsons, UK

Rodrigo Ramos-Zúñiga, Mexico

Albert Roger, Spain

Leyla Sahin, USA

John D. Seeger, USA

Sabine Seisling, the Netherlands

Jim Slattery, UK

Patrick Souverein, the Netherlands

Michael A. Steinman, USA

Wenqing Su, USA

Rolf Teschke, Germany

Judy van Stralen, Canada

Bastiaan Venhuis, the Netherlands

Ami Vyas, USA

Shirley Wang, USA

Chi-Chuan Wang, Taiwan, Republic of China

Stuart J. Warden, USA

Rei Watanabe, Japan

Juanita Westbury, Australia

Saranrat Wittayanukorn, USA

Juan Yang, China

Jinquan Yu, China

In addition, we would like to thank the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:

Darrell R. Abernethy, USA

G. Caleb Alexander, USA

Ariel Beresniak, Switzerland

Howard Birnbaum, USA

Juliana Bottomley, UK

Petra Denig, the Netherlands

Jack E. Fincham, USA

Brian Godman, Sweden

David Goldsmith, USA

Sudeep Karve, USA

Noam Y. Kirson, USA

Chris Kozma, USA

Tamar Lasky, USA

Arduino A. Mangoni, Australia

Suzana Mimica-Matanovic, Croatia

Ankita Modi, USA

Barbara Rinaldi, Italy

Janet K. Sluggett, Australia

Keith A. Swanson, USA

John E. Ware Jr, USA

Quan Zou, USA

We do hope that you have found the articles published throughout the year in Drugs—Real World Outcomes to be interesting and informative. The editorial schedule for 2018 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.

With best wishes from Dene Peters (Editor) and Kathy Fraser (Deputy Editor).